AU2654792A - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- AU2654792A AU2654792A AU26547/92A AU2654792A AU2654792A AU 2654792 A AU2654792 A AU 2654792A AU 26547/92 A AU26547/92 A AU 26547/92A AU 2654792 A AU2654792 A AU 2654792A AU 2654792 A AU2654792 A AU 2654792A
- Authority
- AU
- Australia
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919119467A GB9119467D0 (en) | 1991-09-12 | 1991-09-12 | Chemical compounds |
| GB9119467 | 1991-09-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2654792A true AU2654792A (en) | 1993-04-05 |
Family
ID=10701273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU26547/92A Abandoned AU2654792A (en) | 1991-09-12 | 1992-09-11 | Chemical compounds |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0603314A4 (en) |
| JP (1) | JPH06510545A (en) |
| AU (1) | AU2654792A (en) |
| GB (1) | GB9119467D0 (en) |
| WO (1) | WO1993004686A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999007353A1 (en) * | 1997-08-05 | 1999-02-18 | The Mount Sinai School Of Medicine Of The City University Of New York | USE OF α1A-ADRENERGIC RECEPTOR ANTAGONISTS IN GLAUCOMA THERAPY |
| JP2002542147A (en) * | 1998-12-14 | 2002-12-10 | セレジィ ファーマシューティカルス， インコーポレイテッド | Compositions and methods for the treatment of anorectal disorders |
| WO2003042190A1 (en) | 2001-11-12 | 2003-05-22 | Pfizer Products Inc. | N-alkyl-adamantyl derivatives as p2x7-receptor antagonists |
| PA8557501A1 (en) | 2001-11-12 | 2003-06-30 | Pfizer Prod Inc | BENZAMIDA, HETEROARILAMIDA AND INVESTED AMIDAS |
| AU2003294909B2 (en) | 2002-12-20 | 2007-05-17 | Glaxo Group Limited | Benzazepine derivatives for the treatment of neurological disorders |
| PA8591801A1 (en) | 2002-12-31 | 2004-07-26 | Pfizer Prod Inc | BENZAMID INHIBITORS OF THE P2X7 RECEIVER. |
| US7071223B1 (en) | 2002-12-31 | 2006-07-04 | Pfizer, Inc. | Benzamide inhibitors of the P2X7 receptor |
| ATE355273T1 (en) | 2003-05-12 | 2006-03-15 | Pfizer Prod Inc | BENZAMIDINE INHIBITORS OF THE P2X7 RECEPTOR |
| DE602004017206D1 (en) * | 2003-10-23 | 2008-11-27 | Hoffmann La Roche | BENZAZEPINE DERIVATIVES AS MAO B HEMMER |
| CN1934088A (en) | 2004-02-25 | 2007-03-21 | 伊莱利利公司 | 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| CN1980902A (en) | 2004-06-29 | 2007-06-13 | 辉瑞产品有限公司 | Method for preparing 5-'4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h'1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers |
| SI1926712T1 (en) * | 2005-09-01 | 2010-01-29 | Lilly Co Eli | 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO?áD?åAZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| EP1924578B1 (en) * | 2005-09-01 | 2013-11-06 | Eli Lilly And Company | 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| PT1924560E (en) | 2005-09-01 | 2009-10-23 | Lilly Co Eli | 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| AU2006287202B2 (en) | 2005-09-01 | 2013-01-24 | Eli Lilly And Company | 6-arylalkylamino- 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2c receptor agonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3483185A (en) * | 1966-08-16 | 1969-12-09 | American Home Prod | N-substituted 2,3,4,5-tetrahydro-1h-3-benzazepines |
| ZA792785B (en) * | 1978-07-07 | 1980-08-27 | Smithkline Corp | Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines |
| US4469634A (en) * | 1982-07-29 | 1984-09-04 | Smithkline Beckman Corporation | Allyloxy- and allylthio-2,3,4,5-tetrahydro-1H-3-benzazepines |
| US4683229A (en) * | 1986-03-17 | 1987-07-28 | Smithkline Beckman Corporation | 6-halo-9-alkenyleneoxy-3-alkyl-2,3,4,5-tetrahydro-(1H-3)-benzazepines and their use as selective alpha-adrenergic receptor antagonists |
| EP0285287A3 (en) * | 1987-03-23 | 1990-08-16 | Smithkline Beecham Corporation | 3-benzazepine compounds for use in treating gastrointestinal motility disorders |
-
1991
- 1991-09-12 GB GB919119467A patent/GB9119467D0/en active Pending
-
1992
- 1992-09-11 JP JP5505509A patent/JPH06510545A/en active Pending
- 1992-09-11 AU AU26547/92A patent/AU2654792A/en not_active Abandoned
- 1992-09-11 EP EP9292920317A patent/EP0603314A4/en not_active Ceased
- 1992-09-11 WO PCT/US1992/007694 patent/WO1993004686A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0603314A1 (en) | 1994-06-29 |
| WO1993004686A1 (en) | 1993-03-18 |
| EP0603314A4 (en) | 1994-08-24 |
| GB9119467D0 (en) | 1991-10-23 |
| JPH06510545A (en) | 1994-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1704492A (en) | Chemical compounds | |
| AU1168495A (en) | Chemical compounds | |
| GB9103862D0 (en) | Chemical compounds | |
| GB9105152D0 (en) | Chemical compounds | |
| AU2654792A (en) | Chemical compounds | |
| GB9103770D0 (en) | Chemical compounds | |
| AU2156192A (en) | Chemical compounds | |
| AU1975092A (en) | Compounds | |
| GB9100431D0 (en) | Chemical compounds | |
| AU4604193A (en) | Chemical compound | |
| AU5922994A (en) | Oxazinobenzazole compounds | |
| GB9100637D0 (en) | Chemical compounds | |
| AU2072092A (en) | A87689 compounds | |
| GB9106350D0 (en) | Chemical compounds | |
| GB9100422D0 (en) | Chemical compounds | |
| GB9100428D0 (en) | Chemical compounds | |
| GB9100421D0 (en) | Chemical compounds | |
| GB9106339D0 (en) | Chemical compounds | |
| GB9105202D0 (en) | Chemical compounds | |
| GB9100440D0 (en) | Chemical compounds | |
| GB9107328D0 (en) | Chemical compounds | |
| GB9100423D0 (en) | Chemical compounds | |
| GB9100424D0 (en) | Chemical compounds | |
| GB9104889D0 (en) | Chemical compounds | |
| GB9104888D0 (en) | Chemical compounds |